advancements in the dlbcl treatment landscape
Published 2 years ago • 236 plays • Length 0:46Download video MP4
Download video MP3
Similar videos
-
1:49
updates in the dlbcl treatment landscape
-
1:34
advances and unmet needs in second-line treatment of dlbcl
-
2:32
improving the treatment landscape for dlbcl patients
-
1:53
the current immunotherapeutic landscape for treatment of dlbcl
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
1:03
advancements in mcl treatment
-
1:07
key advancements in the treatment of bpdcn from ebmt 2024
-
10:09
understanding diffuse large b-cell lymphoma with jennifer amengual, md
-
6:54
biomarker-guided treatment of cll in the chemo-free era
-
5:54
day in the life - haematology - dr ellen maxwell
-
1:34
the mutational profile in patients with cll treated with acalabrutinib or ibrutinib
-
1:12
exciting advances in dlbcl: molecular characterization of subtypes & novel immunotherapeutic agents
-
2:34
evolving treatment landscape of dlbcl
-
1:52
an insight into the optimal management of patients with dlbcl
-
3:04
applying molecular understanding of dlbcl to management strategies
-
1:20
improving patient outcomes in ctcl: clinical collaboration and novel agents
-
1:33
zamtocabtagene autoleucel for the treatment of patients with r/r dlbcl
-
1:01
advancements in cml: improving treatment-free remission and novel agents
-
7:16
changes in the classification of dlbcl
-
1:28
how the standard of care for dlbcl is changing with the introduction of novel agents
-
2:25
current and emerging immune therapies in al amyloidosis: updates on hbi0101 & bispecifics
-
1:16
predictors of long-term survival in patients with dlbcl/hgbcl following autosct